Antigen delivery via two molecules on the CD8(-) dendritic cell subset induces humoral immunity in the absence of conventional &quot;danger&quot;

Corbett, AJ; Caminschi, I; McKenzie, BS; Brady, JL; Wright, MD; Mottram, PL; Hogarth, PM; Hodder, AN; Zhan, YF; Tarlinton, DM; Shortman, K; Lew, AM

Antigen delivery via two molecules on the CD8(-) dendritic cell subset induces humoral immunity in the absence of conventional "danger"

Author(s): Corbett, AJ; Caminschi, I; McKenzie, BS; Brady, JL; Wright, MD; Mottram, PL; Hogarth, PM; Hodder, AN; Zhan, YF; Tarlinton, DM; Shortman, K; Lew, AM;
Details: Publication Year 2005-10,Volume 35,Issue #10,Page 2815-2825
Journal Title: EUROPEAN JOURNAL OF IMMUNOLOGY
Publication Type: Journal Article
Abstract: Targeting antigen to dendritic cells (DC) in vivo might be an effective method of modulating immune responses. Given the functional specializations among DC subsets, we investigated how targeting different receptors on different DC subsets may influence antibody (Ab) production. We show here that targeting FIRE (F4/80-like receptor) or CIRE (C-type lectin receptor), two molecules expressed on the surface of immature CD8(-) DC in the mouse, increases Ab production 100-1000-fold over a non-targeted control. This response was equivalent to that achieved with CpG adjuvant. In contrast, targeting CD205, which is primarily expressed on CD8(+) DC, did not elicit an Ab response unless an adjuvant was added. Strong Ab responses in FcR gamma(-/-) mice, and with the use of F(ab')(2) fragments, confirmed that FIRE and CIRE targeting was due to specific rather than FcR or complement binding. Our findings may reflect differences in the ability of CD8(+) and CD8(-) DC subsets to stimulate immune responses in vivo. Although the consensus view is that Ag presentation on DC in their steady state leads to tolerance, the Ab enhancement from FIRE and CIRE targeting in the apparent absence of any "danger" or inflammatory signal would suggest that targeting certain DC molecules can supplant the need for external adjuvants for eliciting immune responses.
Publisher: WILEY-V C H VERLAG GMBH
Keywords: C-TYPE LECTIN; CD4 T-CELLS; IN-VIVO; ANTIBODY-RESPONSES; RECEPTOR DEC-205; DNA VACCINATION; BACTERIAL-DNA; CUTTING EDGE; LYMPH-NODES; DC-SIGN
Publisher's Version: https://doi.org/10.1002/eji.200526100
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2005-10-01 12:00:00